NFG
JAZZ icon

Next Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Next Financial Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$4K Sell
34
-12
-26% -$1.58K ﹤0.01% 2472
2021
Q3 		$6K Sell
46
-63
-58% -$9.52K ﹤0.01% 2199
2021
Q2 		$19K Sell
109
-36
-25% -$6.24K ﹤0.01% 1767
2021
Q1 		$24K Sell
145
-46
-24% -$7.57K ﹤0.01% 1573
2020
Q4 		$32K Buy
+191
New +$28.4K ﹤0.01% 1353
2020
Q2 		– Sell
-1,130
Closed -$113K – 1257
2020
Q1 		$113K Sell
1,130
-221
-16% -$28.6K 0.01% 723
2019
Q4 		$202K Sell
1,351
-24
-2% -$3.27K 0.02% 698
2019
Q3 		$176K Buy
1,375
+175
+15% +$23.5K 0.02% 717
2019
Q2 		$171K Buy
1,200
+47
+4% +$6.32K 0.02% 720
2019
Q1 		$165K Buy
1,153
+1,128
+4,512% +$147K 0.04% 415
2018
Q4 		$3K Hold
25
– – ﹤0.01% 1677
2018
Q3 		$4K Buy
+25
New +$4.3K ﹤0.01% 1198
2017
Q4 		– Sell
-25
Closed -$4K – 849
2017
Q3 		$4K Sell
25
-50
-67% -$7.56K ﹤0.01% 1486
2017
Q2 		$12K Hold
75
– – ﹤0.01% 1260
2017
Q1 		$12K Sell
75
-50
-40% -$6.51K ﹤0.01% 1214
2016
Q4 		$14K Sell
125
-112
-47% -$12.5K ﹤0.01% 1511
2016
Q3 		$29K Buy
+237
New +$31.9K 0.01% 1190
2016
Q2 		– Sell
-775
Closed -$101K – 1798
2016
Q1 		$101K Buy
+775
New +$96.5K 0.04% 424
2015
Q3 		– Sell
-514
Closed -$90K – 1886
2015
Q2 		$90K Buy
514
+138
+37% +$24.8K 0.03% 500
2015
Q1 		$64K Hold
376
– – 0.02% 596
2014
Q4 		$62K Buy
376
+294
+359% +$48.8K 0.02% 585
2014
Q3 		$13K Buy
+82
New +$12.6K ﹤0.01% 1640

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Next Financial Group's JAZZ Position: Q4 2021 in Review

Next Financial Group reduced its Jazz Pharmaceuticals (JAZZ) stake by 26% in Q4 2021, selling an estimated $1.58K and leaving 34 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #2472.

Next Financial Group first reported a position in JAZZ in Q3 2014 and has held it in 22 quarters since. The position peaked at $202K in Q4 2019. 454 funds tracked by Wall St. Rank hold JAZZ as of Q4 2021.

  • Next Financial Group held 34 shares of Jazz Pharmaceuticals worth $4K as of Q4 2021.
  • Next Financial Group sold 12 Jazz Pharmaceuticals shares in Q4 2021, an estimated $1.58K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2472 holding.
  • Next Financial Group first reported a position in Jazz Pharmaceuticals in Q3 2014 and has held it in 22 quarters since.
  • Next Financial Group's Jazz Pharmaceuticals position peaked at $202K in Q4 2019.
  • 454 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.